检索结果 - Fenggong Wang

Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib/II... 由 F. Wang, Xiaoli Wei, Fenggong Wang, Nong Xu, Lin Shen, Guanghai Dai, Xianglin Yuan, Y. Chen, S. Yang, Jiawei Shi, Xiang Hu, Xiandong Lin, Q.Y. Zhang, J. Feng, Yi Ba, Yanshi Liu, W. Li, Yongqian Shu, Yi Jiang, Quan Li, J.W. Wang, H. T. Wu, Hui Feng, Sheng Yao, Rui‐Hua Xu